HDAX Therapeutics is developing targeted therapeutics disorders with enhanced binding, on-target effects, and exquisite brain penetration properties for the safe and efficacious treatment of HDAC-driven pathologies such as brain cancers and neurodegenerative disorders, allowing us to target the disease at its roots.